"HIV-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.
| Descriptor ID |
D015498
|
| MeSH Number(s) |
B04.820.650.589.650.350.410
|
| Concept/Terms |
HIV-2- HIV-2
- Immunodeficiency Virus Type 2, Human
- Human Immunodeficiency Virus Type 2
- Human immunodeficiency virus 2
- Human T-Lymphotropic Virus Type IV
- LAV-2
- HIV-II
- HTLV-IV
- Human T Lymphotropic Virus Type IV
|
Below are MeSH descriptors whose meaning is more general than "HIV-2".
Below are MeSH descriptors whose meaning is more specific than "HIV-2".
This graph shows the total number of publications written about "HIV-2" by people in this website by year, and whether "HIV-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2016 | 2 | 2 | 4 |
| 2017 | 10 | 5 | 15 |
| 2018 | 11 | 6 | 17 |
| 2019 | 3 | 2 | 5 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV-2" by people in Profiles.
-
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus. Emerg Microbes Infect. 2021 Dec; 10(1):810-821.
-
Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain. AIDS Res Hum Retroviruses. 2021 08; 37(8):610-612.
-
Severe coronavirus disease 2019 in a patient with HIV-2 infection. AIDS. 2021 06 01; 35(7):1151-1152.
-
New insights are game-changers in HIV-2 disease management. Lancet HIV. 2019 04; 6(4):e214.
-
HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral. Transfusion. 2019 06; 59(6):2054-2060.
-
Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif. Arch Virol. 2019 May; 164(5):1353-1360.
-
Partial pol Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, India. AIDS Res Hum Retroviruses. 2019 05; 35(5):505-508.
-
Key Viral Adaptations Preceding the AIDS Pandemic. Cell Host Microbe. 2019 01 09; 25(1):27-38.
-
Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population. PLoS One. 2018; 13(10):e0198924.
-
Two novel HLA-B alleles, HLA-B*53:01:17 and -B*58:83, found in patients from Guinea-Bissau. HLA. 2018 12; 92(6):417-418.